Jennie Zhang
About Jennie Zhang
Current Role at Bristol Myers Squibb
Jennie Zhang holds the position of Senior Director of Biometrics at Bristol Myers Squibb, located in the New York City Metropolitan Area. In this role, she leads a high-performing biometrics team tasked with maximizing potential value for patients by optimizing drug development and regulatory submissions. Jennie collaborates closely with departments such as Clinical, Market Access, Medical Affairs, Regulatory, and Commercial teams to support and expand indications.
Previous Experience at Celgene
Jennie Zhang has had a robust career at Celgene, spanning multiple roles over the course of fourteen years. She started as a Senior Statistician from 2006 to 2008, then was promoted to Principal Statistician from 2008 to 2014. This was followed by the role of Associate Director Biostatistics from 2014 to 2018 and finally, Director Biostatistics from 2018 to 2020. During her tenure at Celgene, Jennie gained extensive experience in leading drug development and regulatory submissions focused on hematology and oncology.
Early Career at PPD
Jennie Zhang began her professional journey at PPD, where she served as an Associate Biostatistician from 2001 to 2003 and then as a Biostatistician from 2003 to 2006 in New Jersey. This role formed the foundation of her expertise in biostatistics and her eventual rise in the pharmaceutical industry.
Educational Background
Jennie Zhang achieved her Master's degree in Statistics from Rutgers University, completing her studies in one year from 2000 to 2001. This academic background provided her with the statistical expertise that greatly contributed to her successful career in biostatistics and the pharmaceutical industry.
Industry Contributions
Jennie Zhang has been instrumental in delivering global regulatory submissions for multiple indications in hematology. Her extensive experience in the pharmaceutical industry, particularly in drug development and regulatory submissions, has positioned her as a key collaborator across Clinical, Market Access, Medical Affairs, Regulatory, and Commercial teams.